Modi Ventures
About Modi Ventures
Modi Ventures is a Houston-based early-stage venture capital firm that invests in funds and founders at the intersection of technology and biology, at the forefront of the emerging bioeconomy. It backs technology platforms that have a positive impact on health, and in 2025 it raised an $88 million second fund.
Its focus areas include AI, microfluidics hardware, multiomics, precision medicine, synthetic biology, gene editing, and living therapies. Checks typically range from $100,000 to $5 million. Portfolio companies include Breye Therapeutics, Imagenomix, and Cytospire, and recent activity includes joining Proxima’s $80 million seed round in January 2026.
The firm sees the combination of AI and biology as transforming pharmaceuticals, therapeutics, and disease diagnosis. It publishes insights on the sector and puts a thesis-driven lens on the bioeconomy’s effects on manufacturing, climate, agriculture, space, and human health.
People
- Sahir Ali (Modi), Founder & General Partner